2-(2,6-Dioxo-3-piperidinyl)-4-hydroxyisoindoline-1,3-dione - CAS 5054-59-1
Catalog: |
BB027105 |
Product Name: |
2-(2,6-Dioxo-3-piperidinyl)-4-hydroxyisoindoline-1,3-dione |
CAS: |
5054-59-1 |
Synonyms: |
4-Hydroxy thalidomide; E3 ligase Ligand 2; Thalidomide-4-OH; 4-Hydroxy thalidomide, (+/-)-; 3-Hydroxythalidomide; 4-Hydroxy-thalidomide; α-(3-Hydroxy-phthalimido)-glutarimid; 2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione; 2-(2,6-dioxo-3-piperidinyl)-4-hydroxy-1H-isoindole-1,3(2H)-dione |
IUPAC Name: | 2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindole-1,3-dione |
Description: | Thalidomide-OH is a ligand for E3 ligase used in PROTAC technology. |
Molecular Weight: | 274.23 |
Molecular Formula: | C13H10N2O5 |
Canonical SMILES: | C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)O |
InChI: | InChI=1S/C13H10N2O5/c16-8-3-1-2-6-10(8)13(20)15(12(6)19)7-4-5-9(17)14-11(7)18/h1-3,7,16H,4-5H2,(H,14,17,18) |
InChI Key: | XMPJICVFSDYOEG-UHFFFAOYSA-N |
Boiling Point: | 568.3±45.0 ℃ (Predicted) |
Melting Point: | 273-282 ℃ |
Purity: | > 95 % |
Density: | 1.611±0.06 g/cm3 (Predicted) |
Solubility: | DMSO : ≥ 36.5 mg/mL |
Appearance: | White to off-white solid |
Storage: | 4 ℃, stored under nitrogen *In solvent : -80 ℃, 6 months; -20 ℃, 1 month (stored under nitrogen) |
LogP: | 0.06010 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113248473-A | Preparation and medical application of targeted GSK3 alpha/beta degradation agent | 20210526 |
CN-112961180-A | Fluorine ion fluorescent colorimetric probe and preparation method and application thereof | 20210303 |
CN-112239469-A | Targeted protein degradation c-Met degradation agent and preparation method and application thereof | 20201020 |
CN-112239469-B | Targeted protein degradation c-Met degradation agent and preparation method and application thereof | 20201020 |
WO-2021207291-A1 | Compounds and uses thereof | 20200406 |
PMID | Publication Date | Title | Journal |
5114 | 19760420 | Nicotinamide adenine dinucleotide phosphate linked isocitrate dehydrogenase. Catalytic activation by the reduced coenzyme product of the reaction | Biochemistry |
Complexity: | 503 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 274.05897142 |
Formal Charge: | 0 |
Heavy Atom Count: | 20 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 274.05897142 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 104 Å2 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS